Spondyloarthritis & psoriatic arthritis

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study

RMD OpenPublished Observational nationwide matched cohort study

Authors' conclusion

In Swedish clinical practice, methotrexate use is similar in PsA and RA, both regarding initiation of other DMARDs and methotrexate retention.

Study context

Population
Patients with disease-modifying antirheumatic drug (DMARD)-naïve, newly diagnosed psoriatic arthritis (PsA) starting MTX 2011–2019, Swedish national registers, matched 1:1 to rheumatoid arthritis (RA)
Participants
3,642 vs 3,642
Exposure
Newly diagnosed PsA vs RA starting MTX
  • PsAn = 3,642
  • RAn = 3,642reference
Outcome
Proportions remaining on MTX and not having started another DMARD within 2 years of starting MTX
Follow-up
2 years
Methodological detailsnationwide Swedish registers, logistic regression, non-responder imputation
  • Nationwide Swedish registers
  • Logistic regression
  • Non-responder imputation

Main finding

As reported in the abstract

Remaining on MTX

Observational data: associations, not effects.

Further findings

Not started any other DMARD · 2 years after MTX start

Not started a biological or targeted synthetic DMARD · 2 years after MTX start

OutcomePsARAEstimate
Pain score ≤15 mm on MTX monotherapy · 6 monthsNon-responder imputation26%36%aOR for achieving pain score ≤15 mm 0.63 (95% CI 0.47–0.85)
Global health ≤20 mm on MTX monotherapy · 6 monthsNon-responder imputation32%42%aOR for achieving global health ≤20 mm 0.57 (95% CI 0.42–0.76)
Evaluator-assessed 'remission' on MTX monotherapy · 6 monthsNon-responder imputation20%27%aOR for achieving evaluator-assessed 'remission' 0.54 (95% CI 0.39–0.75)

Original publication

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD Open. Published 12 May 2023. doi:10.1136/rmdopen-2022-002883

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.